From DCAT Value Chain Insights (VCI)
Unilife Corporation, a developer and supplier of injectable drug delivery systems, has appointed David Hastings as chief financial officer (CFO), effective February 23, 2015. He will report to Unilife Chairman and CEO Alan Shortall.
Mr. Hastings most recently served as CFO at the biopharmaceutical company, Incyte Corporation. During his 30 year career, including 15 years as a CFO in the biopharmaceutical industry, Mr. Hastings has held senior financial leadership roles at companies such as ArQule, Inc., Genzyme (now a wholly owned subsidiary of Sanofi), and PriceWaterhouseCoopers.
Dennis Pyers, who has been with Unilife since 2010 will continue to serve as interim CFO until February 23rd, 2015, and will then remain at Unilife as senior vice-president and controller reporting to Mr. Hastings.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription